This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: The Innovations of Aaron Joseph Schetter
Introduction
Aaron Joseph Schetter is an accomplished inventor based in Germantown, MD (US). He has made significant contributions to the field of cancer research, particularly in the area of early-stage lung cancer. His work focuses on identifying novel biomarkers that can aid in the prognosis of this disease.
Latest Patents
Schetter holds a patent for his invention titled "Expression protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer." This patent provides innovative biomarkers, specifically four genes: BRCA1, HIF1A, DLC1, and XPO1, either alone or in combination with miR-21. These biomarkers are crucial for improving the early detection and treatment of lung cancer.
Career Highlights
Aaron Joseph Schetter is currently employed at the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to contribute to groundbreaking research that has the potential to save lives.
Collaborations
Throughout his career, Schetter has collaborated with notable colleagues, including Curtis C Harris and Hirokazu Okayama. These partnerships have enhanced the quality and impact of his research.
Conclusion
Aaron Joseph Schetter's innovative work in identifying biomarkers for early-stage lung cancer exemplifies the importance of research in advancing medical science. His contributions are vital for improving patient outcomes in the fight against cancer.